A novel study has analyzed the cost-effectiveness of different Down syndrome (DS) screening strategies. The result confirms that noninvasive prenatal testing (NIPT) outperforms second-trimester serum ...
Non-invasive prenatal tests (NIPTs) are increasingly an integral part of screening during pregnancies across the world. Research from Amsterdam UMC shows that a pregnant woman's genetic background ...
When discussing the value of screening for 22q, the authors concluded that, “the PPV of cfDNA for 22q11.2DS is higher and the false positive rate is lower than that associated with other accepted ...
A new non-invasive test that examines fetal DNA can pick up genetic abnormalities such as Down's syndrome and, unlike more intrusive tests that may raise the risk of miscarriage, it poses no threat to ...
Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, today announced the launch of IONA ® Care+, a fully comprehensive non-invasive prenatal ...
Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine Non-invasive prenatal testing, or NIPT, now shapes critical ...
MANCHESTER, England & BOGOTÁ, Colombia--(BUSINESS WIRE)--Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results